These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 17418569

  • 41. Gyrase ATPase domain as an antitubercular drug discovery platform: structure-based design and lead optimization of nitrothiazolyl carboxamide analogues.
    Jeankumar VU, Renuka J, Kotagiri S, Saxena S, Kakan SS, Sridevi JP, Yellanki S, Kulkarni P, Yogeeswari P, Sriram D.
    ChemMedChem; 2014 Aug; 9(8):1850-9. PubMed ID: 24962352
    [Abstract] [Full Text] [Related]

  • 42. Scoring ligand similarity in structure-based virtual screening.
    Zavodszky MI, Rohatgi A, Van Voorst JR, Yan H, Kuhn LA.
    J Mol Recognit; 2009 Aug; 22(4):280-92. PubMed ID: 19235177
    [Abstract] [Full Text] [Related]

  • 43. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
    Sriram D, Yogeeswari P, Senthilkumar P, Naidu G, Bhat P.
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
    [Abstract] [Full Text] [Related]

  • 44. Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2'-N-acetyltransferase in Mycobacterium tuberculosis.
    Prabu A, Hassan S, Prabuseenivasan, Shainaba AS, Hanna LE, Kumar V.
    J Mol Graph Model; 2015 Sep; 61():133-40. PubMed ID: 26245695
    [Abstract] [Full Text] [Related]

  • 45. Virtual screening against Mycobacterium tuberculosis dihydrofolate reductase: suggested workflow for compound prioritization using structure interaction fingerprints.
    Kumar A, Siddiqi MI.
    J Mol Graph Model; 2008 Nov; 27(4):476-88. PubMed ID: 18829358
    [Abstract] [Full Text] [Related]

  • 46. Identification of active site residues of chorismate mutase-prephenate dehydrogenase from Escherichia coli.
    Christendat D, Turnbull J.
    Biochemistry; 1996 Apr 09; 35(14):4468-79. PubMed ID: 8605196
    [Abstract] [Full Text] [Related]

  • 47. Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of mycobacterium tuberculosis.
    Manetti F, Magnani M, Castagnolo D, Passalacqua L, Botta M, Corelli F, Saddi M, Deidda D, De Logu A.
    ChemMedChem; 2006 Sep 09; 1(9):973-89. PubMed ID: 16892466
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Integration of ligand and structure based approaches for identification of novel MbtI inhibitors in Mycobacterium tuberculosis and molecular dynamics simulation studies.
    Maganti L, Grandhi P, Ghoshal N.
    J Mol Graph Model; 2016 Nov 09; 70():14-22. PubMed ID: 27639087
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Investigating the structural basis of arylamides to improve potency against M. tuberculosis strain through molecular dynamics simulations.
    Punkvang A, Saparpakorn P, Hannongbua S, Wolschann P, Beyer A, Pungpo P.
    Eur J Med Chem; 2010 Dec 09; 45(12):5585-93. PubMed ID: 20888672
    [Abstract] [Full Text] [Related]

  • 54. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R, Garg P, Bharatam PV.
    J Biomol Struct Dyn; 2015 Dec 09; 33(5):1082-93. PubMed ID: 24875451
    [Abstract] [Full Text] [Related]

  • 55. The MM2QM tool for combining docking, molecular dynamics, molecular mechanics, and quantum mechanics.
    Nowosielski M, Hoffmann M, Kuron A, Korycka-Machala M, Dziadek J.
    J Comput Chem; 2013 Apr 05; 34(9):750-6. PubMed ID: 23233437
    [Abstract] [Full Text] [Related]

  • 56. The two chorismate mutases from both Mycobacterium tuberculosis and Mycobacterium smegmatis: biochemical analysis and limited regulation of promoter activity by aromatic amino acids.
    Schneider CZ, Parish T, Basso LA, Santos DS.
    J Bacteriol; 2008 Jan 05; 190(1):122-34. PubMed ID: 17965159
    [Abstract] [Full Text] [Related]

  • 57. Synthesis and evaluation of C-5 modified 2'-deoxyuridine monophosphates as inhibitors of M. tuberculosis thymidylate synthase.
    Alexandrova LA, Chekhov VO, Shmalenyuk ER, Kochetkov SN, El-Asrar RA, Herdewijn P.
    Bioorg Med Chem; 2015 Nov 15; 23(22):7131-7. PubMed ID: 26482569
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H, Lee KS, Ko YK, Ryu JW, Woo JC, Koo DW, Shin SJ, Ahn SJ, Shin AR, Song CH, Jo EK, Park JK, Kim HJ.
    Int J Antimicrob Agents; 2008 Jun 15; 31(6):567-71. PubMed ID: 18337064
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.